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W illiam B. Schwartz, one of the golden boys of the golden age of nephrology, died on 15 March 2009 at the age of 86. WBS, 
as he was known to those of us who worked 
closely with him, will be long remembered 
not only for his remarkable contributions to 
our understanding of the kidney, but also for 
his pioneering work in decision analysis and, 
most recently, for his prescient insights into the 
arcane world of medical economics.
First, nephrology. WBS can be rightfully 
credited with having been a midwife at the birth 
of modern nephrology. An Alabama native who 
got his BA and MD from Duke, he was one of 
a handful of post-World War II investigators 
who saw an opportunity to apply the still crude 
tools of physiology to unravel the mysteries that 
lay deep within the kidney. Along with such 
venerable founders of our discipline as Don 
Seldin at Southwestern, Lou Welt at the UNC, 
Frank Epstein at Yale, Alex Leaf at Harvard, and 
especially Arnold ‘Bud’ Relman at neighboring 
Boston University, WBS worked his magic at 
Tufts–New England Medical Center. It was Sam 
Proger, the legendary chair of medicine at Tufts 
with an unerring eye for talent, who recognized 
the promise in the 28-year-old Schwartz and 
invited him in 1950 to establish a laboratory 
devoted to the study of this mysterious organ.
Over the next two decades, the Schwartz 
lab made seminal contributions to the foun-
dational literature in this rapidly developing 
field. His discovery that sulfanilamide had 
diuretic properties led to the development of 
acetazolamide, thiazides, and eventually furo-
semide. He and Fred Bartter identified the syn-
drome of inappropriate antidiuretic hormone 
secretion, a condition still known as Schwartz–
Bartter syndrome. His laboratory defined the 
whole-body response to both acute and chronic 
respiratory acidosis and alkalosis, laying the 
groundwork for distinguishing ‘simple’ from 
‘mixed’ acid–base disorders. He established 
the key role of chloride in metabolic alkalosis 
and, with Relman, described the defect in renal 
concentrating ability due to potassium deple-
tion and the defects in acid excretion in renal 
failure. He was also the first to describe spon-
taneous lactic acidosis. The countless journal 
articles, reviews, and textbook chapters that 
WBS authored and coauthored during these 
halcyon days of nephrology had much to do 
with setting the standard of scientific rigor and 
clarity of thought that came to characterize this 
new field.
WBS was also a prolific educator. He trained 
some 60 fellows during his tenure as division 
chief, the great majority of whom went on to 
assume important leadership roles in academic 
medicine. The lessons he taught all of his stu-
dents went far beyond the intricacies of renal 
function or the arcana of acid–base metabo-
lism. His dedication to scientific integrity, his 
unflinching demand for solid evidence before 
reaching a conclusion, and his insistence on the 
precise use of language are indelibly etched in 
the psyches of all of us who were privileged to 
have WBS as a tutor.
In 1971, WBS succeeded Sam Proger as 
chair of Medicine at Tufts and launched the 
second phase of his remarkable career. In vari-
ous collaborations with Jerry Kassirer, Steve 
Pauker, Tony Gorry, and Al Essig, WBS was 
among the very first people to recognize the 
power of formal decision analysis to improve 
the assessment of complex clinical problems. 
The still promising field of artificial intelligence 
owes a sizable debt to these early adopters of 
Bayesian analysis as a means for removing bias 
and increasing the accuracy of diagnosis.
In 1976, WBS was named Vannevar Bush 
University Professor at Tufts University, and 
in 1992 he joined the faculty of the University 
of Southern California to facilitate his new 
collaborations with scholars at the Rand Cor-
poration. It was during these latter decades 
of his illustrious career that WBS widened 
his scholarly horizon to encompass the entire 
health-care system. He and his collaborators 
contributed incisive analyses of a wide range of 
pressing issues, including the impact of rising 
hospital costs, the geographic maldistribution 
of specialists, and the adverse influence of 
malpractice insurance.
Arguably the most provocative and far-
reaching of his views was the prediction that 
the United States would eventually need to 
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explicitly ration health care to avoid the dire 
economic consequences of escalating health-
care expenditures. Schwartz’s 1984 book The 
Painful Prescription: Rationing Hospital Care, 
which he wrote with the economist Henry J. 
Aaron, put this controversial issue squarely 
on the health-policy agenda. He argued that 
technology-driven advances in medical care 
would inevitably confront society with a painful 
choice: either allow an ever increasing fraction 
of our country’s resources to go for health care, 
or stanch the cost escalation by prospectively 
limiting access to particular treatments.
WBS also penned Life Without Disease: The 
Pursuit of Medical Utopia and coauthored Can 
We Say No? The Challenge of Rationing Health 
Care and Coping with Methuselah: The Impact 
of Molecular Biology on Medicine and Society. 
In addition, he wrote innumerable thought 
pieces for the health-policy community and for 
the popular press, all of which challenged his 
readers to grapple with emerging issues that his 
incomparable intellect recognized more quickly 
and grasped more clearly than virtually anyone 
else in the country.
Few can claim to have truly advanced even 
one field of study. Fewer still, two. Virtually 
none, three. William B. Schwartz belongs in 
that last, rarefied group. The fields of nephrol-
ogy, clinical decision analysis, and health policy 
all bear the undying stamp of his brilliance. He 
was intellectually restless, uncompromisingly 
rigorous, and incessantly curious. We are not 
likely to see his equal any time soon.
